180 related articles for article (PubMed ID: 27160525)
21. Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas.
Egan RJ; Iliff H; Stechman MJ; Scott-Coombes DM
World J Surg; 2018 Sep; 42(9):2835-2839. PubMed ID: 29497805
[TBL] [Abstract][Full Text] [Related]
22. Importance of intraoperative parathyroid hormone measurement in the diagnosis of parathyroid lipoadenoma.
Lee AY; Wang BY; Heller KS
Head Neck; 2011 Jun; 33(6):917-9. PubMed ID: 20091680
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound combined with biochemical parameters can predict parathyroid carcinoma in patients with primary hyperparathyroidism.
Liu R; Xia Y; Chen C; Ye T; Huang X; Ma L; Hu Y; Jiang Y
Endocrine; 2019 Dec; 66(3):673-681. PubMed ID: 31489590
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid carcinoma.
Butt WT; Azim A; Abbas A; Gauhar TM; Afzal A; Azim KM
J Coll Physicians Surg Pak; 2012 Sep; 22(9):588-90. PubMed ID: 22980615
[TBL] [Abstract][Full Text] [Related]
25. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
Mazeh H; Chen H; Leverson G; Sippel RS
Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
[TBL] [Abstract][Full Text] [Related]
26. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.
Robert JH; Trombetti A; Garcia A; Pache JC; Herrmann F; Spiliopoulos A; Rizzoli R
Ann Surg Oncol; 2005 Jul; 12(7):526-32. PubMed ID: 15889214
[TBL] [Abstract][Full Text] [Related]
27. The Parathyroid carcinoma: a diagnostic challenge before surgery.
Kane BS; Sow M; Diagne N; Badji N; Seck M; Akpo G; Cheikh Ndao A; Djiba B; Faye A; Ndongo S; Pouye A
Tunis Med; 2019 Feb; 97(2):383-387. PubMed ID: 31539099
[TBL] [Abstract][Full Text] [Related]
28. Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism.
Mizrachi A; Gilat H; Bachar G; Feinmesser R; Shpitzer T
Head Neck; 2009 Nov; 31(11):1456-60. PubMed ID: 19405085
[TBL] [Abstract][Full Text] [Related]
29. A nationwide study on parathyroid carcinoma.
Ryhänen EM; Leijon H; Metso S; Eloranta E; Korsoff P; Ahtiainen P; Kekäläinen P; Tamminen M; Ristamäki R; Knutar O; Löyttyniemi E; Niskanen L; Väisänen M; Heiskanen I; Välimäki MJ; Laakso M; Haglund C; Arola J; Schalin-Jäntti C
Acta Oncol; 2017 Jul; 56(7):991-1003. PubMed ID: 28362521
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid carcinoma: sixteen new cases and suggestions for correct management.
Favia G; Lumachi F; Polistina F; D'Amico DF
World J Surg; 1998 Dec; 22(12):1225-30. PubMed ID: 9841748
[TBL] [Abstract][Full Text] [Related]
31. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case.
Ito Y; Iwase H; Tanaka H; Yuasa H; Kureyama Y; Yamashita H; Toyama T; Kimura M; Kobayashi S
Surg Today; 2001; 31(10):895-8. PubMed ID: 11759885
[TBL] [Abstract][Full Text] [Related]
32. Factors Influencing Time to Decrease in Intraoperative Parathyroid Hormone (ioPTH) Levels in Patients Undergoing Focused Parathyroidectomy (FP).
Bhutiani N; Graffree B; Martin RCG; Quillo AR
Am Surg; 2018 Jun; 84(6):772-775. PubMed ID: 29981600
[TBL] [Abstract][Full Text] [Related]
33. Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report.
Kawagishi S; Funaki S; Ose N; Kimura K; Mukai K; Otsuki M; Shintani Y
J Cardiothorac Surg; 2021 Apr; 16(1):86. PubMed ID: 33858470
[TBL] [Abstract][Full Text] [Related]
34. Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients.
Rajaei MH; Oltmann SC; Adkisson CD; Elfenbein DM; Chen H; Carty SE; McCoy KL
Surgery; 2014 Oct; 156(4):760-6. PubMed ID: 25239313
[TBL] [Abstract][Full Text] [Related]
35. [Primary hyperparathyroidism due to parathyroid carcinoma].
Megino Moreno T; Herranz Antolín S; Bernal Bello D; Alvarez De Frutos V
Endocrinol Nutr; 2010 Dec; 57(10):504-6. PubMed ID: 20951655
[No Abstract] [Full Text] [Related]
36. Controversies in the management of parathyroid carcinoma: A case series and review of the literature.
Medas F; Erdas E; Loi G; Podda F; Pisano G; Nicolosi A; Calò PG
Int J Surg; 2016 Apr; 28 Suppl 1():S94-8. PubMed ID: 26708847
[TBL] [Abstract][Full Text] [Related]
37. Oncologic progress for the treatment of parathyroid carcinoma is needed.
Christakis I; Silva AM; Kwatampora LJ; Warneke CL; Clarke CN; Williams MD; Grubbs EG; Lee JE; Busaidy NL; Perrier ND
J Surg Oncol; 2016 Nov; 114(6):708-713. PubMed ID: 27753088
[TBL] [Abstract][Full Text] [Related]
38. The relationship between proliferation activity and parathyroid hormone levels in parathyroid tumors.
Inic Z; Inic M; Jancic S; Paunovic I; Tatic S; Tausanovic K; Zivavljevic V; Zegarac M; Inic I; Dunjdjerovic D
J BUON; 2015; 20(2):562-6. PubMed ID: 26011350
[TBL] [Abstract][Full Text] [Related]
39. Extensive brown tumors caused by parathyroid adenoma in an adolescent patient.
Atabek ME; Pirgon O; Sert A; Esen HH
Eur J Pediatr; 2008 Jan; 167(1):117-9. PubMed ID: 17273830
[TBL] [Abstract][Full Text] [Related]
40. Primary hyperparathyroidism due to parathyroid carcinoma.
Mendoza V; Hernández AF; Márquez ML; Delgadillo MA; Peña J; Mercado M
Arch Med Res; 1997; 28(2):303-6. PubMed ID: 9204627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
